Cancer Diagnostics
|2 min read
Men More Likely Than Women to Receive Later-Stage Cancer Diagnoses, Study Finds
Analysis of 2.4 million US cases from the NCI-SEER database shows men are more often diagnosed at regional or metastatic stages across multiple cancer types
|2 min read
New Blood Test Detects Testicular Cancers Missed by Standard Markers
Mayo Clinic researchers have developed two new blood tests that use immune system signals to improve detection and classification of testicular germ cell tumors
|3 min read
Labcorp, CHOP Partner to Expand Access to Pediatric Diagnostics Nationwide
The partnership focuses on accelerating development of pediatric diagnostics across rare disease, oncology, and metabolic conditions
|2 min read
Researchers Analyze the Performance of GIFT, a Web-Based Cascade Testing Portal that Clinical Labs Could Use
With more than 250,000 cancer patients undergoing genetic testing this year, researchers are turning to web portals and AI to manage family notifications
|2 min read
CAP Updates Cancer Protocols, Clarifies MMR/MSI Testing Discordance in New Article
The updates underscore shifts toward more standardized cancer reporting and more integrated interpretation of MMR/MSI testing in clinical decision-making
|2 min read
Beyond Snapshots: How AI Is Redefining Cancer Diagnosis and Treatment
AI positions the clinical laboratory as both a diagnostic endpoint and a partner in patient care
Updated |3 min read
Researchers Develop Low-Cost Blood Test to Detect Multiple Cancers from a Single Sample
The method analyzes genome-wide DNA methylation in blood to detect liver, lung, ovarian, and stomach cancers, as well as other diseases
|2 min read
Amplified Sciences Achieves CAP Accreditation for Cutting-Edge Diagnostic Lab
Gold standard milestone clears the path for national expansion of PanCystPro™ assay
|3 min read
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery
Positive results from the RETAIN-2 trial demonstrate that a response-adapted bladder-preservation approach involving neoadjuvant chemoimmunotherapy can be considered in select patients
|1 min read
Standardizing Oncology Assays: A Guide to Cell Line-Derived Reference Materials
Identify the limitations of patient tissue controls in genetic testing and examine the verification data supporting cell line-derived standardsSponsored by
|1 min read
Move Past the Limitations of Synthetic Reference Standards in Cancer Research
A review of cell line-derived reference standards for the investigation and molecular profiling of myeloid malignanciesSponsored by
|3 min read
The Future of Companion Diagnostics: A Multi-Omics Revolution
The landscape of companion diagnostics is poised for transformative growth, driven by technological innovation, expanding therapeutic applications, and evolving regulatory support
|2 min read
